Lab testing in Maine is a story of two systems. The adult-use market operates under rigorous, mandatory testing enforced by the Office of Cannabis Policy (OCP) under 18-691 C.M.R. Chapter 1. Every recreational product must pass independent laboratory analysis before reaching a dispensary shelf. The medical program and caregiver system operate under Chapter 2, which requires no mandatory testing for pesticides, mold, heavy metals, or potency. This is Maine's most consequential cannabis policy gap — and the data behind it is alarming.

Adult-Use: Mandatory Testing

All cannabis products sold in Maine's adult-use market must be tested by one of the state's 4 licensed independent testing facilities before they can be approved for sale. This is a non-negotiable requirement of the adult-use regulatory framework.

Required Testing Categories

• Potency analysis — THC, THCA, CBD, CBDA, and total cannabinoid content
• Pesticide screening — Panel of prohibited pesticide compounds with defined action limits
• Heavy metals — Lead, arsenic, cadmium, and mercury at established thresholds
• Microbial contamination — Mold, yeast, E. coli, Salmonella, and total aerobic bacterial count
• Residual solvents — For concentrates and extracts made using chemical solvents
• Mycotoxins — Toxic compounds produced by certain molds (aflatoxins, ochratoxin A)
• Moisture content — For flower products to prevent mold growth

The Testing Process

1. Sample collection: A licensed sample collector (a separate license type in Maine) takes a representative sample from each production batch
2. Metrc tracking: The sample is tracked through Maine's seed-to-sale system from collection to results
3. Laboratory analysis: The licensed lab performs all required tests using validated analytical methods
4. Certificate of Analysis (COA): The lab issues a COA documenting all test results
5. Pass/fail determination: Products meeting all OCP standards are approved; products that fail are quarantined and cannot be sold
6. Retail release: Only products with passing COAs can be transferred to dispensaries

Lab Independence

Maine requires testing laboratories to operate independently from all other cannabis license types. A testing facility owner cannot hold any other cannabis license. This structural separation is designed to prevent conflicts of interest. With only 4 licensed testing facilities operating statewide (as of December 2024), capacity is limited but growing.

Medical and Caregiver: No Mandatory Testing

This is the critical distinction. Maine's medical cannabis program and caregiver system — governed by 18-691 C.M.R. Chapter 2 — do not require mandatory laboratory testing. Caregivers and medical dispensaries:

• Are not required to test for pesticides, heavy metals, mold, or potency
• Do not use Metrc electronic tracking (paper records only)
• Can sell products to patients without any third-party verification of safety or potency
• May voluntarily test, but there is no mechanism to verify or enforce it

The OCP study analyzed a range of medical cannabis samples under adult-use testing standards. Results showed 42 to 45 percent of medical samples would have failed mandatory testing requirements, including samples with pesticide residues up to 293 times the allowable threshold.

Office of Cannabis Policy, 2023 Medical Cannabis Testing Study

The Testing Gap: What the Data Shows

The gap between adult-use testing standards and the absence of medical testing is not theoretical. Two key data points illustrate the risk:

2023 OCP Study

The OCP conducted a study analyzing medical cannabis samples against the testing standards applied to adult-use products. Key findings:

• 42–45% of medical samples would have failed adult-use testing standards
• One sample contained pesticide residues at 293 times the acceptable threshold
• Failures included pesticides, microbial contamination, and heavy metals
• Potency labels on untested products were often inaccurate

January 2026 Waterville Patient Advisory

In January 2026, the OCP issued a public patient advisory after testing of products from a Waterville-area caregiver revealed pesticide contamination at 190 times the acceptable threshold. This incident — coming three years after the initial study — demonstrated that the problem persists in the absence of mandatory testing.

LD 1847: The Push for Universal Testing

LD 1847 is pending legislation that would impose mandatory testing requirements on Maine's medical cannabis program and caregiver system, bringing them in line with adult-use standards. The bill has generated intense debate:

Arguments For LD 1847

• Patient safety — Medical patients, including immunocompromised individuals, are consuming untested products
• The OCP data is clear: nearly half of medical samples fail adult-use standards
• Patients deserve the same safety protections as recreational consumers
• Potency accuracy is essential for medical dosing

Arguments Against LD 1847

• Cost burden on caregivers — Testing adds significant expense to small operations running on thin margins
• Only 4 testing labs statewide — Capacity concerns for 1,539+ caregivers
• The caregiver model's affordability and accessibility could be threatened
• Some view it as an attempt to undermine the caregiver system through regulatory burden

LD 1847 remains one of the most actively debated cannabis policy issues in Maine. Whatever your position, the underlying data about contamination in untested products is a consumer safety issue that every buyer should understand.

Understanding Certificates of Analysis

A Certificate of Analysis (COA) is the official lab report for a specific batch. When reviewing a COA, look for:

• Cannabinoid profile: THC, THCA, CBD, CBDA, and total cannabinoid percentages or milligrams
• Terpene profile: Individual terpene concentrations (when tested)
• Contaminant results: Pass/fail status for pesticides, heavy metals, microbials, and solvents
• Lab accreditation: Confirmation that the lab is OCP-licensed
• Date of testing: When the analysis was performed
• Batch/lot number: Should match the number on your product's label